Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Fenchem Enterprises Ltd.
March 28, 2008
1 Min Read
CHINO, Calif.—Targeting the U.S. mood product market, Fenchem (Fenchem.com) will launch a new product, SAMe-way™. According to the company, SAM-e (S-adenosyl-methionine) is a prescription medication in European countries used to treat depression and joint pain, but is sold as a supplement in the United States, where annual sales were close to $100 million in 2007. SAM-way is available in two forms of Ademetionine 1,4-butanedisulfonate and Ademetionine disulfate tosylate
You May Also Like